IL-33 potentiates histaminergic itch

Authors

Anna M Trier, Washington University School of Medicine in St. Louis
Aaron M Ver Heul, Washington University School of Medicine in St. Louis
Avery Fredman, Washington University School of Medicine in St. Louis
Victoria Le, Mount Sinai School of Medicine
Zhen Wang, Mount Sinai School of Medicine
Kelsey Auyeung, Mount Sinai School of Medicine
James Meixiong, Johns Hopkins University
Paola Lovato, LEO Pharma A/S
Michael J Holtzman, Washington University School of Medicine in St. Louis
Fang Wang, Sun Yat-sen University
Xinzhong Dong, Johns Hopkins University
Andrew L Ji, Mount Sinai School of Medicine
Brian S Kim, Mount Sinai School of Medicine

Journal

The Journal of allergy and clinical immunology

Publication Date

3-1-2024

Volume

153

Issue

3

First Page

852

Last Page

859

Document Type

Open Access Publication

DOI

10.1016/j.jaci.2023.08.038

Rights and Permissions

Trier AM, Ver Heul AM, Fredman A, Le V, Wang Z, Auyeung K, Meixiong J, Lovato P, Holtzman MJ, Wang F, Dong X, Ji AL, Kim BS. IL-33 potentiates histaminergic itch. J Allergy Clin Immunol. 2024 Mar;153(3):852-859.e3. doi: 10.1016/j.jaci.2023.08.038 Copyright 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Trier, Anna M; Ver Heul, Aaron M; Fredman, Avery; Le, Victoria; Wang, Zhen; Auyeung, Kelsey; Meixiong, James; Lovato, Paola; Holtzman, Michael J; Wang, Fang; Dong, Xinzhong; Ji, Andrew L; and Kim, Brian S, "IL-33 potentiates histaminergic itch." The Journal of allergy and clinical immunology. 153, 3. 852 - 859. (2024).
https://digitalcommons.wustl.edu/oa_4/4027

Department

ICTS (Institute of Clinical and Translational Sciences)